Pricing Log in Create free account

Immunocore Holdings PLC Sponsored ADR (IMCR) vs Rapport Therapeutics, Inc. (RAPP)

Immunocore Holdings PLC Sponsored ADR and Rapport Therapeutics, Inc. are both Biotechnology companies. Immunocore Holdings PLC Sponsored ADR and Rapport Therapeutics, Inc. are of similar size ($1.5B and $1.4B). Rapport Therapeutics, Inc. has the higher net margin (0.00% vs −4.20%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Rapport Therapeutics, Inc. leads on 7 and Immunocore Holdings PLC Sponsored ADR on 5.

Valuation

Metric IMCR RAPP Biotechnology median
P/E n/m n/m 8.50
P/S 3.48 n/m 9.71
P/B 3.57 3.09 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.46 n/m 9.21
Earnings yield (1.22%) (11.03%) (33.15%)
Free cash flow yield (2.75%) (7.41%) (25.50%)

Profitability

Metric IMCR RAPP Biotechnology median
Gross margin 98.90% — 65.16%
Operating margin (5.24%) 0.00% 0.00%
Net margin (4.20%) 0.00% 0.00%
Free cash flow margin (9.55%) 0.00% 0.00%
Return on equity (4.47%) (39.96%) (56.36%)
Return on assets (1.64%) (36.85%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMCR RAPP Biotechnology median
Revenue growth (TTM) 20.95% — 6.02%
EPS growth (last fiscal year) 30.39% 24.34% 30.26%
Revenue growth, 5-year CAGR 59.57% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IMCR RAPP Biotechnology median
Debt to equity 0.94 0.00 0.00
Current ratio 4.47 15.72 4.72
Net debt to EBITDA 11.19 3.91 0.96

Dividend

Metric IMCR RAPP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMCR RAPP Biotechnology median
Market cap 1.52b 1.42b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack